awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33855483-C23B79AA-8E04-4AF6-831C-59067DFEFF88
Q33855483-C23B79AA-8E04-4AF6-831C-59067DFEFF88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33855483-C23B79AA-8E04-4AF6-831C-59067DFEFF88
Optimizing the dose and duration of therapy for chronic hepatitis C.
P2860
Q33855483-C23B79AA-8E04-4AF6-831C-59067DFEFF88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33855483-C23B79AA-8E04-4AF6-831C-59067DFEFF88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
654caedc9cb58bac95426de430f9d91aeec85d47
P2860
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.